Food and Drug Administration has moved to extend Pfizer and Moderna’s emergency authorizationVaccine for all adults, the companies announced Friday, as health officials are clamoring to remove a potential of cases this winter.
The Centers for Disease Control and Prevention must also weigh in with its recommendations before the third dose can be officially green-lit under the federal supply agreements governing the use of the shots. But a growing number of state and local health departments do not wait and havetheir own.
A panel of CDC’s external vaccine advisors, the Advisory Committee on Immunization Practices, is scheduled to meet Friday afternoon to vote on the updated recommendations.
“Enough is enough. Let’s continue here. We know what the data is. Let’s do it, 18 years and older, everyone should be vaccinated, should be healthy,” said Dr. Anthony Fauci, medical advisor the president’s chief economic officer, said Wednesday night. at a webinar organized by the team ThisIsOurShot.
Fauci is on the list of top Biden administration doctors who for months have called for enhanced recommendations. guidance currently limits the third dose of Pfizer and Moderna to seniors and adults with underlying medical conditions or in “high-risk settings” six months after they were first immunized.for all adults, instead of narrower
All recipients of Johnson & Johnson’s Janssen COVID-19 vaccine were eligible for a booster shot two months after their first shot.
More than 31 million vaccinated Americans – more than 17% of all vaccinated to date – have received a booster shot, according to CDC’s data. medium tempo booster injections have slowed in recent weeks, down more than 15 percent from their peak at the end of October.
Booster vaccination advocates cite growing data from the United States and abroad showing that vaccine effectiveness declines over time for both infection and hospitalization. In the United Kingdom, researchers at Imperial College London Report this week that those who received the booster dose had a three times lower risk of infection than those who received only two doses.
FDA’s external vaccine advisers earlier this year initially balked at Pfizer’s broad request to license the booster for all adults, amid concerns about the risk of myocarditis — a type of myocarditis. Vaccination-associated heart inflammation is rare in most young men. The FDA has authorized Moderna’s boosters with similar limits.
However, top FDA officials have pointed to data from countries like Israel that do not show evidence of an increased risk after a third Pfizer vaccination. Moderna’s chief medical officer told reporters last week that the company has not seen any reports of myocarditis so far after rolling out a third wave in other countries.
An FDA spokesperson decided not to convene its own vaccine advisers to discuss whether to authorize Pfizer and Moderna’s requests, as officials “concluded that they did not submit question benefited from additional discussion by committee members.”
Regardless of the decisions of the agencies, leaders ofcommitted to self-move to allow boosters for all adults like climbed across the country.
“We’re optimistic that the message from Minnesota and many other states has been heard and that the federal government is about to announce that expansion,” Jan Malcolm, Minnesota’s top health official, told reporters in Near day. news conference.
Only three jurisdictions are predicted to see a decline in new hospital admissions over the next month, according to the CDC’s country team forecast. Nationwide, the CDC this week lowered its death toll outlook for the first time in months, no longer predicting that the pandemic’s death toll would “likely decrease” in the coming weeks.
Minnesota ranks among the top 10 states guess to see the next week’s peak hospitalization rate.
“I would like to say that, given the very dire situation we are in here in Minnesota, we have communicated with our federal partners that we are preparing to proceed independently this week to expand our eligible for enhanced if no action is taken at the federal level, which we will certainly have this week,” Malcolm said.
https://www.cbsnews.com/news/covid-vaccine-booster-shot-fda-authorization/ FDA approves COVID vaccine booster for all adults